- Supported exchanges /
- NSE /
- SYNCOMF.NSE
Syncom Formulations (India) Limited (SYNCOMF NSE) stock market data APIs
Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India. It operates through Manufacturing and Dealing in Pharmaceutical Drug & Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, gynae, opthal, ortho, and pediatrics formulations. It provides life care, evolve, and right nutrition products under the Cratus brand. In addition, the company engages in the trading of commodities and renting of properties. It also exports its products. The company offers its pharmaceutical formulations products in various dosage forms, such as tablets, capsules, ointments, injections, liquids orals, and effervescent. Syncom Formulations (India) Limited was incorporated in 1988 and is based in Indore, India.
Syncom Formulations (India) Limited Financial Data Overview
19.68 | |
19.74 | |
- | |
19.98 | |
19.58 | |
10.55-27.9 | |
18 593 M | |
50.718 | |
940 M | |
3 289 M | |
1.495 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Syncom Formulations (India) Limited Fundamental Data is available in our Financial Data APIs
- Net Revenue 3 289 M
- EBITDA 388 M
- Earnings Per Share 0.39
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Syncom Formulations (India) Limited Earnings via APIs
- Latest Release 2024-11-06
- EPS/Forecast NaN
Get Syncom Formulations (India) Limited End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: